āshibio

Brisbane, United States

āshibio is a privately held biotechnology business exploring innovative therapies to treat bone and connective tissue ailments.

$40.0M raised

Jun 2024

Series A

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has āshibio raised?

āshibio has raised $40.0M in total funding. The most recent round was Series A. The last funding was announced in June 2024.

Who are āshibio's investors?

āshibio's investors include MPM Capital, Agent Capital, Mirae Asset Venture Investment, YK Bioventures.

Where is āshibio headquartered?

āshibio is headquartered in Brisbane, United States.

What does āshibio do?

āshibio is a privately held biotechnology business exploring innovative therapies to treat bone and connective tissue ailments.

What stage is āshibio at?

āshibio is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 20, 2024.

MLA

"āshibio — Funding & Investors." VCBacked, June 20, 2024, https://www.vcbacked.co/company/shibio. Accessed July 2, 2026.

APA

VCBacked. (2024). āshibio — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/shibio

Wikipedia (cite web)

{{cite web |title=āshibio — Funding & Investors |url=https://www.vcbacked.co/company/shibio |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 20, 2024.